Patents by Inventor Thomas Richard

Thomas Richard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210160374
    Abstract: A method, a computer program product, and a computer system determine when to transfer a communication session from an agent to a bot. The method includes monitoring the communication session between the agent and a user. The method includes determining a continuing utility value indicating a predicted continuing cost to maintaining the communication session with the agent. The continuing utility value is indicative of a predicted continuing benefit to maintaining the communication with the agent. The method includes determining a transferring utility value indicating a predicted transferring cost to transferring the communication session from the agent to the bot. The transferring utility value is indicative of a predicted transferring benefit to transferring the communication session from the agent to the bot. The method includes, as a result of the predicted transferring benefit being greater than the predicted continuing benefit, transferring the communication session from the agent to the bot.
    Type: Application
    Filed: November 26, 2019
    Publication date: May 27, 2021
    Inventors: John Thomas Richards, Rachel Katherine Emma Bellamy, Robert G. Farrell, Qingzi Liao, David John Piorkowski
  • Publication number: 20210127475
    Abstract: Systems and methods for providing dynamic lighting are provided. In an exemplary aspect, one or more characteristics of light provided from a lighting device or a group of lighting devices changes over time to shape the environment of an indoor space according to dynamic lighting instructions. Dynamic lighting may improve the health or wellbeing of individuals in an indoor space, for example, by simulating an outdoor environment to reduce stress, by providing circadian entrainment to improve sleep and wakefulness, or the like. Other aspects of the present disclosure enable lighting devices to provide light that is synchronized with one or more other devices and does not significantly drift over time so that the lighting devices can provide seamless dynamic lighting experiences that shape the environment of an indoor space.
    Type: Application
    Filed: October 28, 2020
    Publication date: April 29, 2021
    Inventors: Ronald W. Bessems, Matthew Brian Deese, Kory Alexander Liszt, John W. Frailey, Shane Michael O'Donnell, Ronald Lee Fienberg, Thomas Richard Hinds, Gary David Trott
  • Publication number: 20210101943
    Abstract: In one aspect, the invention relates to a composition including a first polypeptide having the sequence set forth in SEQ ID NO: 1 and a second polypeptide having the sequence set forth in SEQ ID NO: 2. In one embodiment, the composition includes about 120 ?g/ml of a first polypeptide including the amino acid sequence set forth in SEQ ID NO: 1, 120 ?g/ml of a second polypeptide including the amino acid sequence set forth in SEQ ID NO: 2, about 2.8 molar ratio polysorbate-80 to the first polypeptide, about 2.8 molar ratio polysorbate-80 to the second polypeptide, about 0.5 mg/ml aluminum, about 10 mM histidine, and about 150 mM sodium chloride. In one embodiment, a dose of the composition is about 0.5 ml in total volume. In one embodiment, two-doses of the composition induce a bactericidal titer against diverse heterologous subfamily A and subfamily B strains in a human.
    Type: Application
    Filed: December 18, 2020
    Publication date: April 8, 2021
    Inventors: Annaliesa Sybil Anderson, Rasappa Gounder Arumugham, John Erwin Farley, Leah Diane Fletcher, Shannon Lea Harris, Kathrin Ute Jansen, Thomas Richard Jones, Lakshmi Khandke, Bounthon Loun, John Lance Perez, Gary Warren Zlotnick
  • Publication number: 20210085773
    Abstract: In one aspect, the invention relates to a composition including a first polypeptide having the sequence set forth in SEQ ID NO: 1 and a second polypeptide having the sequence set forth in SEQ ID NO: 2. In one embodiment, the composition includes about 120 ?g/ml of a first polypeptide including the amino acid sequence set forth in SEQ ID NO: 1, 120 ?g/ml of a second polypeptide including the amino acid sequence set forth in SEQ ID NO: 2, about 2.8 molar ratio polysorbate-80 to the first polypeptide, about 2.8 molar ratio polysorbate-80 to the second polypeptide, about 0.5 mg/ml aluminum, about 10 mM histidine, and about 150 mM sodium chloride. In one embodiment, a dose of the composition is about 0.5 ml in total volume. In one embodiment, two-doses of the composition induce a bactericidal titer against diverse heterologous subfamily A and subfamily B strains in a human.
    Type: Application
    Filed: December 8, 2020
    Publication date: March 25, 2021
    Applicant: Pfizer Inc.
    Inventors: Kathrin Ute Jansen, Annaliesa Sybil Anderson, Rasappa Gounder Arumugham, John Erwin Farley, Leah Diane Fletcher, Shannon Lea Harris, Thomas Richard Jones, Lakshmi Khandke, Bounthon Loun, John Lance Perez, Gary Warren Zlotnick
  • Publication number: 20210083545
    Abstract: A method of mounting a rotor assembly to a frame of an electric motor includes providing a rotor assembly having a bearing and a frame having a bearing seat. The method includes locating the bearing within the bearing seat, applying a first adhesive at a substantially hidden interface between the bearing and the bearing seat, applying a second adhesive at a substantially visible interface between the bearing and the bearing seat, and curing the first and second adhesives using different curing processes.
    Type: Application
    Filed: February 19, 2019
    Publication date: March 18, 2021
    Applicant: Dyson Technology Limited
    Inventors: David IONS, John Declan STOTT, Thomas Richard STAFFORD
  • Patent number: 10941052
    Abstract: Embodiments of the invention provide a piston assembly for a control valve in a water softener system. The control valve includes a drive mechanism, one or more fluid passageways, and a seal assembly. The piston assembly includes a main piston moveably received within the seal assembly and including a first end and a second end opposite to the first end, and a shuttle piston moveably received within the seal assembly. The shuttle piston includes a first end and a second end opposite to the first end, and is configured to selectively engage the second end of the main piston to form a seal therebetween and to selectively move relative to the second end of the main piston to form an opening between the second end of the main piston and the first end of the shuttle piston, in response to movement of the main piston.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: March 9, 2021
    Assignee: PENTAIR RESIDENTIAL FILTRATION, LLC
    Inventors: Scott Thomas Mueller, Thomas Richard Bednar, Peter W. Shefte
  • Publication number: 20210065720
    Abstract: Embodiments included herein generally relate to using non-audio data embedded in an audio signal. More particularly, embodiments relate to using non-audio data embedded into the audio signal to control an audio configuration of a plurality of speakers and/or to measure a delay of a playback device.
    Type: Application
    Filed: August 28, 2019
    Publication date: March 4, 2021
    Applicant: Roku, Inc.
    Inventors: Thomas Richard Henry Dewey, Robert Caston CURTIS
  • Publication number: 20210038559
    Abstract: This invention provides processes and compositions for enhancing the immunogenicity of tumor or infected cells by increasing expression of major histocompatibility complex (MHC) class I surface molecules. Tumor cells often circumvent immune recognition by reducing or eliminating MHC expression. The lack of MHC on their surface allows tumor cells to evade immune detection and enables uncontrolled growth. Similarly, certain viral or microbial infections result in MHC class I downregulation and the resulting immune evasion. With a unique reporter assay, we have determined that some cannabinoid compounds and structural analogs can increase MHC class I expression on tumor cells grown in cell culture. The increase of tumor and infected cell MHC class I expression will enable detection and destruction by cytotoxic T-lymphocyte cells. The process and compositions increase the immunogenicity of the target cells, e.g. tumor or infected cells, to enhance their destruction by cytotoxic lymphocytes.
    Type: Application
    Filed: January 22, 2019
    Publication date: February 11, 2021
    Inventors: Thomas Richard GADAK, Patrick William GRAY, Wilfred Arthur JEFFERIES
  • Patent number: 10904606
    Abstract: Embodiments included herein generally relate to measuring a latency of a playback device. For example, a method includes: determining a first latency of a playback device; determining a second latency of the playback device; comparing the second latency to the first latency to determine whether an event occurred at the playback device; and in response to detecting a latency change between the second latency and the first latency indicating the occurrence of the event, adjusting a timing of a data stream provided to the playback device based on the latency change.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: January 26, 2021
    Assignee: Roku, Inc.
    Inventor: Thomas Richard Henry Dewey
  • Patent number: 10899802
    Abstract: In one aspect, the invention relates to a composition including a first polypeptide having the sequence set forth in SEQ ID NO: 1 and a second polypeptide having the sequence set forth in SEQ ID NO: 2. In one embodiment, the composition includes about 120 ?g/ml of a first polypeptide including the amino acid sequence set forth in SEQ ID NO: 1, 120 ?g/ml of a second polypeptide including the amino acid sequence set forth in SEQ ID NO: 2, about 2.8 molar ratio polysorbate-80 to the first polypeptide, about 2.8 molar ratio polysorbate-80 to the second polypeptide, about 0.5 mg/ml aluminum, about 10 mM histidine, and about 150 mM sodium chloride. In one embodiment, a dose of the composition is about 0.5 ml in total volume. In one embodiment, two-doses of the composition induce a bactericidal titer against diverse heterologous subfamily A and subfamily B strains in a human.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: January 26, 2021
    Assignee: PFIZER INC.
    Inventors: Annaliesa Sybil Anderson, Rasappa Gounder Arumugham, John Erwin Farley, Leah Diane Fletcher, Shannon Lea Harris, Kathrin Ute Jansen, Thomas Richard Jones, Lakshmi Khandke, Bounthon Loun, John Lance Perez, Gary Warren Zlotnick
  • Publication number: 20210019833
    Abstract: A method is disclosed including receiving data relating to the determination of an optimal plan design, and storing the received data in memory on at least one computer; formulating, as optimization questions, a plurality of questions related to determination of an optimal plan design; storing the optimization questions in memory on at least one computer; delivering the optimization questions to a plurality of respondents; receiving, as optimization responses, responses to the optimization questions; creating, as optimization rules, a plurality of rules for using received data and optimization responses to determine an optimized plan design; storing the optimization rules in memory in at least one computer, and performing in a computer an optimization process that applies the optimization rules to the received data and optimization responses in order to determine an optimized plan design.
    Type: Application
    Filed: October 6, 2020
    Publication date: January 21, 2021
    Applicant: Bdellium, Inc.
    Inventors: Richard Christopher Dunne, Thomas Richard Kmak
  • Publication number: 20210013765
    Abstract: An electric motor has a rotor assembly having a bearing, and a frame having a bearing seat. The bearing is received within the bearing seat. The bearing is secured to the bearing seat by a first adhesive located at a hidden interface defined between the bearing and the bearing seat. The bearing seat has a cut-out, and a portion of the bearing is exposed through the cut-out. The bearing is secured to the bearing seat by a second adhesive located at the cut-out.
    Type: Application
    Filed: February 19, 2019
    Publication date: January 14, 2021
    Applicant: Dyson Technology Limited
    Inventors: David IONS, John Declan STOTT, Thomas Richard STAFFORD
  • Patent number: 10888611
    Abstract: In one aspect, the invention relates to a composition including a first polypeptide having the sequence set forth in SEQ ID NO: 1 and a second polypeptide having the sequence set forth in SEQ ID NO: 2. In one embodiment, the composition includes about 120 ?g/ml of a first polypeptide including the amino acid sequence set forth in SEQ ID NO: 1, 120 ?g/ml of a second polypeptide including the amino acid sequence set forth in SEQ ID NO: 2, about 2.8 molar ratio polysorbate-80 to the first polypeptide, about 2.8 molar ratio polysorbate-80 to the second polypeptide, about 0.5 mg/ml aluminum, about 10 mM histidine, and about 150 mM sodium chloride. In one embodiment, a dose of the composition is about 0.5 ml in total volume. In one embodiment, two-doses of the composition induce a bactericidal titer against diverse heterologous subfamily A and subfamily B strains in a human.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: January 12, 2021
    Assignee: PFIZER INC.
    Inventors: Kathrin Ute Jansen, Annaliesa Sybil Anderson, Rasappa Gounder Arumugham, John Erwin Farley, Leah Diane Fletcher, Shannon Lea Harris, Thomas Richard Jones, Lakshmi Khandke, Bounthon Loun, John Lance Perez, Gary Warren Zlotnick
  • Publication number: 20210006121
    Abstract: A method of mounting a rotor assembly to a frame of an electric motor. The method includes providing a rotor assembly having a bearing and a frame having a bearing seat. The bearing seat has an aperture. The bearing and/or the internal surface of the bearing seat has an annular groove. The method includes locating the bearing within the bearing seat. The method includes injecting an adhesive through the aperture into the annular groove. The method includes affecting relative movement between the bearing and the bearing seat. The method includes curing the adhesive.
    Type: Application
    Filed: February 19, 2019
    Publication date: January 7, 2021
    Applicant: Dyson Technology Limited
    Inventors: David IONS, John Declan STOTT, Thomas Richard STAFFORD
  • Publication number: 20200405838
    Abstract: In one aspect, the invention relates to a composition including a factor H binding protein (fHBP) and a Neisseria meningitidis non-serogroup B capsular polysaccharide. The invention further relates to uses of a composition that includes fHBP, such as, for example, uses to elicit an immune response against N. meningitidis serogroup B strains and non-serogroup B strains. The compositions and methods described herein are directed to administration in humans, including adults, adolescents, toddlers, and infants.
    Type: Application
    Filed: September 17, 2020
    Publication date: December 31, 2020
    Applicant: PFIZER INC.
    Inventors: Kathrin Ute Jansen, Annaliesa Sybil Anderson, Judith Absalon, Jose Miguel Aste-Amezaga, Johannes Frederik Beeslaar, David Cooper, John Erwin Farley, Leah Diane Fletcher, Shannon Lea Harris, Thomas Richard Jones, Isis Kanevsky, Lakshmi Khandke, Paul Liberator, John Lance Perez, Lynn Marie Phelan, Gary Warren Zlotnick
  • Patent number: 10830833
    Abstract: A coaxial cable testing assembly includes an electrically conductive fixture including first and second sections, and an electrically conductive radio frequency (RF) connector pin carried by an electrically insulative body carried by the second section. The pin extends away from the receiving area from a connection end of the pin proximate to the receiving area and through and beyond the body to a connector end of the pin. An inner contact is electrically connected to the pin at the connection end. An outer contact is electrically connected to the fixture. The inner and outer contacts electrically contact coaxial inner and outer conductors, respectively, of the end of the coaxial cable, the body electrically isolates the RF connector pin from the fixture, and the fixture frictionally engages the coaxial cable, when the end of the coaxial cable is inserted into the receiving area.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: November 10, 2020
    Inventor: Thomas Richard Brinkoetter
  • Publication number: 20200339889
    Abstract: A remote hydrocarbon processing system comprising a gas compressor skid, gas processing skid, electric power generation skid, liquid storage tank, blending skid, and crude oil source, are fluid flow interconnected and located proximate to a producing well. Produced gases are delivered from the well to the gas compressor skid. Compressed natural gas is delivered to the gas processing skid where it is thermally separated to generate a processed gas stream and a processed liquid stream. The processed gas stream is delivered to the electric power generation skid and burned to generate electricity that may be delivered to an electric power transmission line. The processed liquid stream is delivered to the liquid storage tank. Crude oil from the crude oil source and processed liquid stream from the liquid storage tank are delivered to the Blending skid and blended into a lower viscosity, higher API gravity transportable crude oil.
    Type: Application
    Filed: April 29, 2020
    Publication date: October 29, 2020
    Applicant: Chrisma Energy Solutions, LP
    Inventors: Thomas Richard Mechler, Melea Rachel Bonasso
  • Patent number: 10813989
    Abstract: In one aspect, the invention relates to a composition including a factor H binding protein (fHBP) and a Neisseria meningitidis non-serogroup B capsular polysaccharide. The invention further relates to uses of a composition that includes fHBP, such as, for example, uses to elicit an immune response against N. meningitidis serogroup B strains and non-serogroup B strains. The compositions and methods described herein are directed to administration in humans, including adults, adolescents, toddlers, and infants.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: October 27, 2020
    Assignee: Pfizer Inc.
    Inventors: Kathrin Ute Jansen, Annaliesa Sybil Anderson, Judith Absalon, Jose Miguel Aste-Amezaga, Johannes Frederik Beeslaar, David Cooper, John Erwin Farley, Leah Diane Fletcher, Shannon Lea Harris, Thomas Richard Jones, Isis Kanevsky, Lakshmi Khandke, Paul Liberator, John Lance Perez, Lynn Marie Phelan, Gary Warren Zlotnick
  • Publication number: 20200263531
    Abstract: A pumpjack monitor includes a processor and memory, a communicator for communicating with other monitors and a server, a sensor module having at least one strain gauge, and accelerometers for determining vibration and position of the monitor. Other sensors may be internal, including sensors for polished-rod rotation, and linked to the monitoring device wirelessly. Some embodiments serve as network hubs or bridges for other monitors. The server is configured to generate surface cards. A method for monitoring of pumpjacks uses the monitor to sense changes in pumpjack parameters, and communicate the changes to a server when changes exceed configurable thresholds. Some embodiments include determining location with GPS and/or relaying signals from other monitoring devices, smart power management, gas sensing, and relaying of signals from external wireless-equipped sensors such as valve position sensors, oil level sensors, and pressure sensors.
    Type: Application
    Filed: September 12, 2018
    Publication date: August 20, 2020
    Inventors: Kelly Fyfe, Kipling William Fyfe, Thomas Richard Williams
  • Patent number: D906450
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: December 29, 2020
    Inventor: Thomas Richard Schaefer